
OptimizeRx Corp (OPRX) P/E Ratio
P/E Ratio as of Jun 13, 2025: -16.97
Average-15.49
Median-14.69
Minimum-18.37
Maximum-12.67
-16.97
Past Month-4.94 (41.06%)
The P/E ratio for OptimizeRx Corp (OPRX) is -16.97 as of Jun 13, 2025. This represents a increase of 141.05% compared to its 12-month average P/E ratio of -7.04. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.
OptimizeRx Corp P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
OptimizeRx Corp’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing OptimizeRx Corp to industry peers.
OptimizeRx Corp P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
OptimizeRx Corp’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing OptimizeRx Corp to industry peers.
OptimizeRx Corp (OPRX) P/E Ratio Insights
See OptimizeRx Corp’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in OptimizeRx Corp (OPRX)
Order type
Buy in
Order amount
Est. shares
0 shares
OptimizeRx Corp (OPRX) P/E Ratio Historic Data
Date | Stock price | P/E ratio |
---|---|---|
Jun 2, 2025 | $12.35 | -14.69 |
May 1, 2025 | $9.64 | -8.75 |
Apr 1, 2025 | $8.18 | -7.43 |
Mar 3, 2025 | $4.87 | -3.67 |
Feb 3, 2025 | $5.73 | -4.32 |
Jan 2, 2025 | $5.21 | -3.93 |
OptimizeRx Corp (OPRX) End of Year P/E Ratio
Date | P/E ratio | Change |
---|---|---|
2025 | -16.97 | +362.40% |
2024 | -3.67 | -79.22% |
2023 | -17.66 | -38.64% |
2022 | -28.78 | -100.74% |
2021 | 3906.29 | -2,107.03% |
2020 | -194.63 | — |
FAQs About OptimizeRx Corp (OPRX) P/E ratio
The latest P/E ratio of OptimizeRx Corp (OPRX) is -16.97, as of Jun 13, 2025. This is calculated based on its current stock price and earnings per share (EPS).
OptimizeRx Corp’s last 12-month average P/E ratio is -7.04, compared to its current P/E ratio of -16.97. This reflects a increase of 141.05%.
OptimizeRx Corp’s current P/E ratio of -16.97 is higher than its last 12-month average P/E of -7.04. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.
OptimizeRx Corp’s average P/E ratio over the last 3 years is -17.67. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.
OptimizeRx Corp’s average P/E ratio over the last 5 years is 197.85. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.